Home/Filings/4/0001209191-21-031435
4//SEC Filing

Butt Tausif 4

Accession 0001209191-21-031435

CIK 0001340652other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 7:48 PM ET

Size

5.0 KB

Accession

0001209191-21-031435

Insider Transaction Report

Form 4
Period: 2021-05-07
Butt Tausif
EVP, Chief Operating Officer
Transactions
  • Purchase

    Common Stock

    2021-05-07$11.06/sh+10,870$120,24110,870 total
Footnotes (1)
  • [F1]Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $11.02 to $11.12 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

Issuer

ChemoCentryx, Inc.

CIK 0001340652

Entity typeother

Related Parties

1
  • filerCIK 0001845266

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 7:48 PM ET
Size
5.0 KB